metaplastic vs. tnbc: comparing long-term outcomes
Published 3 years ago • 764 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
3:13
atezolizumab in metastatic tnbc: long-term clinical outcomes and biomarker analyses
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
32:04
educational sessions: "management of special subtypes of tnbc"
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
59:04
let's talk about it: tnbc ask me anything: long-term side effects of cancer treatment
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes
-
5:03
triple negative breast cancer (tnbc) | dr rachel dear
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
3:28
immunotherapy in early-stage tnbc - where do we stand?
-
33:30
neelima denduluri, md -- treatment of triple negative breast cancer
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
1:02
evaluating the role of neoadjuvant chemotherapy and surgery in stage i tnbc
-
23:20
what is metaplastic breast cancer?
-
0:38
metaplastic breast cancer introduction
-
0:54
oncology appointments for metastatic triple negative breast cancer #tnbc #breast cancer #radiation
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
43:41
revolutionising triple negative breast cancer treatment
-
1:09
treating patients with metaplastic breast cancer
-
50:33
treatment and issues for triple negative breast cancer-may 14, 2020